top of page
About
Our goal is to provide treatments for solid tumors where other immunotherapies have fallen short – using high affinity and specific modalities without immune overactivation and cytokine response syndrome.
Poseidon is a privately held, pre-clinical biotechnology company bringing forward its modular Trident platform engineered to engage T cells specifically with cancer cells in the tumor microenvironment.
Company Overview
bottom of page